Anesthesia Drugs Market in U.S. worth $7 Billion by 2015: MarketsandMarkets
DALLAS, May 17, 2012 /PRNewswire/ –
The “Anesthesia Drugs Market (2011 – 2015) – U.S. Market Entry Study
” analyzes and studies the U.S. market for intravenous anesthesia drugs with special
focus on ketamine, distribution structure of anesthesia drugs in U.S., potential buyers,
export & import system for controlled substances in U.S. and U.S. market entry strategy.
Browse market data tables and in-depth TOC of “Anesthesia Drugs Market (2011 – 2015) -
U.S.Market Entry Study”.
Early buyers will receive 10% customization on reports.
This report studies the U.S. Ketamine market over the period of 2007-2015. Ketamine
market is expected to grow at a moderate rate from 2011 to 2016. Anesthesia is a condition
in which sensation is totally or partially blocked. This enables the patients to undergo
medical procedures and surgery. Based on the applications (type of surgery or medical
procedure) anesthetic drugs are broadly categorized into two types; i.e. local anesthetic
drugs and general anesthetic drugs. Local anesthesia is a condition when sensation within
a specific body part in inhibited, where as general anesthesia results in loss of
consciousness and sensation.
General anesthesia includes blockage of pain, awareness, and memory. Advantages
offered by general anesthesia includes – rapid onset of anesthesia, full control of the
body processes (airway, respiratory and circulatory system), used in surgeries with
unpredictable duration of surgery, no memory of the surgery, allows complete
motionlessness over prolonged duration of the surgery and it permits simultaneous
operation on different body parts.
General anesthesia drugs involve inhalation and intravenous anesthesia drugs. Report
is specially focused on general intravenous anesthesia drugs category. Drugs such as
propofol, midazolam & diazepam, fospropofol disodium, sodium pentothal, ketamine,
methohexital sodium, pentobarbital, etomidate, and fentanyl are studied.
The U.S. general anesthesia drugs market size was approximately $2 billion in 2011 and
is expected to grow at a moderate rate, with a CAGR of approximately 4% from 2011 to 2015.
In addition, intravenous anesthetic drugs accounted for the largest share -65% – of the
U.S. general anesthetics drugs market in 2011.
Ketamine is an anesthetic drug mainly used for initiation and maintenance of general
anesthesia in humans. It belongs to NMDA receptor antagonist class, which includes
molecules that prevent the action of the N-methyl D-aspartate (NMDA) receptor. Factors
such as increase in aging population, rising cardiovascular, and respiratory system
related diseases and rising number of emergency surgeries will help in maintaining stable
growth in the ketamine market revenue in the next five years along with the overall growth
of the U.S. general intravenous anesthesia market.
MarketsandMarkets is a global market research and consulting company based in the U.S.
We publish strategically analyzed market research reports and serve as a business
intelligence partner to Fortune 500 companies across the world.
MarketsandMarkets also provides multi-client reports, company profiles, databases, and
custom research services. MarketsandMarkets covers thirteen industry verticals; including
advanced materials, automotives and transportation, banking and financial services,
biotechnology, chemicals, consumer goods, energy and power, food and beverages, industrial
automation, medical devices, pharmaceuticals [
semiconductor and electronics and telecommunications and IT.
We at MarketsandMarkets are inspired to help our clients grow by providing apt
business insight with our huge market intelligence repository. To know more about us and
our reports, please visit our website http://www.marketsandmarkets.com.
Contact: Mr. Rohan North - Dominion Plaza, 17304 Preston Road, Suite 800, Dallas, TX 75252 Tel: +1-888-6006-441 Email: firstname.lastname@example.org MarketsandMarkets Blog @ http://www.marketsandmarketsblog.com http://twitter.com/marketsmarkets